Please use this identifier to cite or link to this item:
Type of publication: conference paper
Type of publication (PDB): Konferencijų tezės nerecenzuojamuose leidiniuose / Conference theses in non-peer-reviewed publications (T2)
Field of Science: Biochemija / Biochemistry (N004)
Author(s): Degutytė-Fomins, Laima;Šilkūnienė, Giedrė;Trumbeckaitė, Sonata;Jasukaitienė, Aldona;Sukovas, Artūras;Naučienė, Zita;Gulbinas, Antanas;Mildažienė, Vida
Title: Hyperthermia enhances sensitivity of Ovcar-3 cells to cisplatin
Is part of: 15th international conference of the Lithuanian biochemical society, Dubingiai, June 26-29, 2018 : program and abstract book. Vilnius : Lithuanian biochemical society, 2018
Extent: p. 74-75
Date: 2018
Note: This research was funded by a grant (No. SEN-01/2015) from the Research Council of Lithuania
Keywords: Ovcar-3 cells;Cisplatin;Hyperthermia;Ovarian cancer
ISBN: 9786099603001
Abstract: Ovarian cancer is the most common cancer for women. Hyperthermic chemotherapy is used aiming to overcome the resistance of cancer cells to cisplatin and to reduce cisplatin doses. Due to the shift in energy metabolism of certain types of cancer to aerobic glycolysis (Warburg effect), glutamate dehydrogenase (GDH) was suggested as an attractive anticancer target, because mitochondria in cancer cells became producers of non-essential amino acids from tricarboxylic acid (TCA) intermediates and exports excess of citrate to cytosol to support fatty acid synthesis and NADPH production. Given that GDH is an enzyme converting glutamate to TCA intermediate α-ketoglutarate, it acquires an important role in Ovarian cancer cell viability. However, the interaction of GDH with common anticancer drugs as well as changes in GDH activity upon the hyperthermia treatment of cancer cells remained uninvestigated. The aim of this study was to investigate the effects of mild hyperthermia (40°C and 43°C for 1h), cisplatin IC50 or combination of both treatments on GDH activity, respiration and cell viability immediately after hyperthermic treatment (0h) and after 24 and 48h recovery at 37°C in Ovcar-3 cell line. Cisplatin inhibits GDH in Ovcar-3 cells, however not immediately after treatment, but only after 24 or 48h recovery by 40 and 60%, respectively. That possibly indicates to indirect inhibition effect (e.g., effect on GDH expression). Hyperthermia (43°C) in the absence of cisplatin strongly stimulates GDH in Ovcar-3 cells, however this effect is pronounced only immediately after treatment and diminished with time to the levelof control. Combination of cisplatin and temperature had greater (by 10%) effect on GDH activity as compared with cisplatin effect alone, however significant difference only detected at 43°C temperature at 0 and 48h. [...]
Affiliation(s): Biochemijos katedra
Lietuvos sveikatos mokslų universitetas
Lietuvos sveikatos mokslų universitetas. Medicinos akademija
Lietuvos sveikatos mokslų universitetas. Medicinos akademija. Virškinimo sistemos tyrimų institutas
Vytauto Didžiojo universitetas
Appears in Collections:Universiteto mokslo publikacijos / University Research Publications

Files in This Item:
marc.xml8.67 kBXMLView/Open

MARC21 XML metadata

Show full item record
Export via OAI-PMH Interface in XML Formats
Export to Other Non-XML Formats

CORE Recommender

Page view(s)

checked on May 1, 2021


checked on May 1, 2021

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.